BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 36704655)

  • 1. Liver injury on admission linked to worse outcomes in COVID-19: an analysis of 14,138 patients.
    Chela HK; Tallon EM; Baskett W; Gangu K; Tahan V; Shyu CR; Daglilar E
    Transl Gastroenterol Hepatol; 2023; 8():4. PubMed ID: 36704655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal liver chemistries as a predictor of COVID-19 severity and clinical outcomes in hospitalized patients.
    Krishnan A; Prichett L; Tao X; Alqahtani SA; Hamilton JP; Mezey E; Strauss AT; Kim A; Potter JJ; Chen PH; Woreta TA
    World J Gastroenterol; 2022 Feb; 28(5):570-587. PubMed ID: 35316959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal Liver Tests in COVID-19: A Retrospective Observational Cohort Study of 1,827 Patients in a Major U.S. Hospital Network.
    Hundt MA; Deng Y; Ciarleglio MM; Nathanson MH; Lim JK
    Hepatology; 2020 Oct; 72(4):1169-1176. PubMed ID: 32725890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-adjusted mortality and predictive value of liver chemistries in a Viennese cohort of COVID-19 patients.
    Hartl L; Haslinger K; Angerer M; Jachs M; Simbrunner B; Bauer DJM; Semmler G; Scheiner B; Eigenbauer E; Strassl R; Breuer M; Kimberger O; Laxar D; Trauner M; Mandorfer M; Reiberger T
    Liver Int; 2022 Jun; 42(6):1297-1307. PubMed ID: 35412018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of liver abnormalities with in-hospital mortality in patients with COVID-19.
    Ding ZY; Li GX; Chen L; Shu C; Song J; Wang W; Wang YW; Chen Q; Jin GN; Liu TT; Liang JN; Zhu P; Zhu W; Li Y; Zhang BH; Feng H; Zhang WG; Yin ZY; Yu WK; Yang Y; Zhang HQ; Tang ZP; Wang H; Hu JB; Liu JH; Yin P; Chen XP; Zhang B;
    J Hepatol; 2021 Jun; 74(6):1295-1302. PubMed ID: 33347952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated liver enzymes portends a higher rate of complication and death in SARS-CoV-2.
    Currier EE; Dabaja M; Jafri SM
    World J Hepatol; 2021 Sep; 13(9):1181-1189. PubMed ID: 34630884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronavirus disease (COVID-19) and the liver: a comprehensive systematic review and meta-analysis.
    Kumar-M P; Mishra S; Jha DK; Shukla J; Choudhury A; Mohindra R; Mandavdhare HS; Dutta U; Sharma V
    Hepatol Int; 2020 Sep; 14(5):711-722. PubMed ID: 32623633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum Activity of Liver Enzymes Is Associated With Higher Mortality in COVID-19: A Systematic Review and Meta-Analysis.
    Boregowda U; Aloysius MM; Perisetti A; Gajendran M; Bansal P; Goyal H
    Front Med (Lausanne); 2020; 7():431. PubMed ID: 32793616
    [No Abstract]   [Full Text] [Related]  

  • 9. Longitudinal Association Between Markers of Liver Injury and Mortality in COVID-19 in China.
    Lei F; Liu YM; Zhou F; Qin JJ; Zhang P; Zhu L; Zhang XJ; Cai J; Lin L; Ouyang S; Wang X; Yang C; Cheng X; Liu W; Li H; Xie J; Wu B; Luo H; Xiao F; Chen J; Tao L; Cheng G; She ZG; Zhou J; Wang H; Lin J; Luo P; Fu S; Zhou J; Ye P; Xiao B; Mao W; Liu L; Yan Y; Liu L; Chen G; Li H; Huang X; Zhang BH; Yuan Y
    Hepatology; 2020 Aug; 72(2):389-398. PubMed ID: 32359177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic changes in liver function parameters in patients with coronavirus disease 2019: a multicentre, retrospective study.
    Zeng QL; Yu ZJ; Ji F; Li GM; Zhang GF; Xu JH; Lin WB; Zhang GQ; Li GT; Cui GL; Wang FS
    BMC Infect Dis; 2021 Aug; 21(1):818. PubMed ID: 34399709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal liver tests in patients with SARS-CoV-2 or influenza - prognostic similarities and temporal disparities.
    Shafran N; Issachar A; Shochat T; Shafran IH; Bursztyn M; Shlomai A
    JHEP Rep; 2021 Jun; 3(3):100258. PubMed ID: 33644724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence, risk factors, and prognosis of abnormal liver biochemical tests in COVID-19 patients: a systematic review and meta-analysis.
    Wu Y; Li H; Guo X; Yoshida EM; Mendez-Sanchez N; Levi Sandri GB; Teschke R; Romeiro FG; Shukla A; Qi X
    Hepatol Int; 2020 Sep; 14(5):621-637. PubMed ID: 32710250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 Infection Induces a Dual Response in Liver Function Tests: Association with Mortality during Hospitalization.
    Bernal-Monterde V; Casas-Deza D; Letona-Giménez L; de la Llama-Celis N; Calmarza P; Sierra-Gabarda O; Betoré-Glaria E; Martínez-de Lagos M; Martínez-Barredo L; Espinosa-Pérez M; M Arbones-Mainar J
    Biomedicines; 2020 Sep; 8(9):. PubMed ID: 32899640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver involvement is not associated with mortality: results from a large cohort of SARS-CoV-2-positive patients.
    Ponziani FR; Del Zompo F; Nesci A; Santopaolo F; Ianiro G; Pompili M; Gasbarrini A;
    Aliment Pharmacol Ther; 2020 Sep; 52(6):1060-1068. PubMed ID: 32628793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does Raised Transaminases Predict Severity and Mortality in Patients with COVID 19?
    Kodavoor Vadiraj P; Thareja S; Raman N; Karantha SC; Jayaraman M; Vardhan V
    J Clin Exp Hepatol; 2022; 12(4):1114-1123. PubMed ID: 35125781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased Serum Aminotransferase Activity and Clinical Outcomes in Coronavirus Disease 2019.
    Ramachandran P; Perisetti A; Gajendran M; Chakraborti A; Narh JT; Goyal H
    J Clin Exp Hepatol; 2020; 10(6):533-539. PubMed ID: 32837096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal Liver Function Tests Were Associated With Adverse Clinical Outcomes: An Observational Cohort Study of 2,912 Patients With COVID-19.
    Lv Y; Zhao X; Wang Y; Zhu J; Ma C; Feng X; Ma Y; Zheng Y; Yang L; Han G; Xie H
    Front Med (Lausanne); 2021; 8():639855. PubMed ID: 34179034
    [No Abstract]   [Full Text] [Related]  

  • 18. Hepatocellular injury and the mortality risk among patients with COVID-19: A retrospective cohort study.
    Madian A; Eliwa A; Abdalla H; Aly HAA
    World J Hepatol; 2021 Aug; 13(8):939-948. PubMed ID: 34552700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of liver injury and correlation with clinical outcomes in patients with COVID-19: systematic review with meta-analysis.
    Del Zompo F; De Siena M; Ianiro G; Gasbarrini A; Pompili M; Ponziani FR
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):13072-13088. PubMed ID: 33378061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of COVID-19 on the liver: The experience of a single center.
    Liakina V; Stundiene I; Milaknyte G; Bytautiene R; Reivytyte R; Puronaite R; Urbanoviciute G; Kazenaite E
    World J Gastroenterol; 2022 Oct; 28(39):5735-5749. PubMed ID: 36338891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.